ACETIC ACID - acetic acid solution 
Rising Pharmaceuticals, Inc.

----------

Acetic Acid Otic Solution USP, 2%

DESCRIPTION

Acetic Acid Otic Solution USP is a nonaqueous solution of glacial acetic acid, USP (2%), in a propylene glycol vehicle containing benzethonium chloride, USP (0.02%); propylene glycol diacetate, NF (3%) and sodium acetate, USP (0.015%). It may also contain citric acid, USP.

The molecular formula for acetic acid is CH3COOH, with a molecular weight of 60.05. The structural formula is:

structure

Acetic Acid Otic Solution is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

CLINICAL PHARMACOLOGY

Acetic acid is anti-bacterial and anti-fungal; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

INDICATIONS AND USAGE

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial.

CONTRAINDICATIONS

Hypersensitivity to Acetic Acid Otic Solution or any of the ingredients. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

WARNINGS

Discontinue promptly if sensitization or irritation occurs.

PRECAUTIONS

Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

PEDIATRIC USE

Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

ADVERSE REACTIONS

Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

DOSAGE AND ADMINISTRATION

Carefully remove all cerumen and debris to allow Acetic Acid Otic Solution to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with the solution into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of the solution every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Acetic Acid Otic Solution 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

HOW SUPPLIED

Acetic Acid Otic Solution USP, 2% is available in 15 mL (NDC 64980-424-15) measured-drop, safety- tip plastic bottles.

STORAGE

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]

KEEP CONTAINER TIGHTLY CLOSED

Rx Only


Distributed by:
Rising Pharmaceuticals, Inc.
Saddle Brook, NJ 07663

Rev. 05/2018

MADE IN USA

Rev. 12/2018

PRINCIPAL DISPLAY PANEL - 15 mL bottle

Rising®

NDC 64980-424-15

Acetic Acid Otic

Solution USP, 2%

DO NOT USE IF BAND PRINTED
"SEALED FOR YOUR PROTECTION”
AROUND CAP IS BROKEN OR MISSING.

15 mL

Rx only

bottle

PRINCIPAL DISPLAY PANEL - 15 mL Carton

Rising®


NDC 64980-424-15


Acetic Acid


Otic Solution


USP, 2%


DO NOT USE IF BAND


PRINTED "SEALED FOR


YOUR PROTECTION"


AROUND CAP IS BROKEN


OR MISSING"


15mL


Rx only


carton


ACETIC ACID 
acetic acid solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:64980-424
Route of AdministrationAURICULAR (OTIC)
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ACETIC ACID (UNII: Q40Q9N063P) (ACETIC ACID - UNII:Q40Q9N063P) ACETIC ACID20 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
PROPYLENE GLYCOL DIACETATE (UNII: 5Z492UNF9O)  
BENZETHONIUM CHLORIDE (UNII: PH41D05744)  
SODIUM ACETATE (UNII: 4550K0SC9B)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:64980-424-151 in 1 CARTON03/14/201810/30/2023
115 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20728003/14/201810/30/2023
Labeler - Rising Pharmaceuticals, Inc. (041241766)

Revised: 7/2022
 
Rising Pharmaceuticals, Inc.